Adverum Biotechnologies Reports Third Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Adverum Biotechnologies (ADVM) Misses Q3 EPS by 5c
November 10, 2022 4:28 PM ESTAdverum Biotechnologies (NASDAQ: ADVM) reported Q3 EPS of ($0.40), $0.05 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.
... More